Should You Sell Eli Lilly To Buy Bristol-Myers Squibb?
- Tuesday, May 5, 2020, 7:16
- Market
- Add a comment
The pharmaceutical companies have not been immune to the current coronavirus crisis, although they have fared much better than the broader markets. While Bristol-Myers Squibb has declined -3.5% since early February, after the WHO declared the coronavirus a global health emergency…
About the Author
admin123 has written 23447 stories on this site.
